Table 5 Odds ratios variables independently associated with treatment choice identified by multivariate regression analysis
From: Management of osteoporosis and associated quality of life in post menopausal women
Variable | Treatment modality (Reference: Weekly BP) | Physician speciality | Odds Ratio | P |
|---|---|---|---|---|
Age | Monthly bisphosphonates | 0.998 [0.982; 1.015] | 0.8544 | |
Strontium ranelate | 0.978 [0.957; 1.000] | 0.0451 | ||
SERM | 0.909 [0.882; 0.938] | < 0.0001 | ||
Paraclinical investigations | Monthly bisphosphonates | 2.158 [1.086; 4.288] | 0.0281 | |
Strontium ranelate | 1.451 [0.608; 3.463] | 0.4017 | ||
SERM | 0.495 [0.213; 1.152] | 0.1028 | ||
Osteoporotic fractures | Monthly bisphosphonates | 0.851 [0.632; 1.144] | 0.2851 | |
Strontium ranelate | 1.631 [1.104; 2.411] | 0.0141 | ||
SERM | 0.501 [0.300; 0.837] | 0.0083 | ||
Physician speciality | Monthly bisphosphonates | Rheumatologists | 1.00 | . |
Gynaecologists | 0.908 [0.510; 1.618] | 0.7431 | ||
GPs | 1.475 [1.051; 2.071] | 0.0247 | ||
Strontium ranelate | Rheumatologists | 1.00 | . | |
Gynaecologists | 2.653 [1.486; 4.734] | 0.0010 | ||
GPs | 0.605 [0.396; 0.924] | 0.0020 | ||
SERM | Rheumatologists | 1.00 | . | |
Gynaecologists | 2.153 [1.081; 4.289] | 0.0292 | ||
GPs | 0.857 [0.482; 1.524] | 0.5998 | ||
Ongoing treatment at the time of consultation | Monthly bisphosphonates | 0.573 [0.426; 0.771] | 0.0002 | |
Strontium ranelate | 1.107 [0.751; 1.633] | 0.6063 | ||
SERM | 0.928 [0.577; 1.492] | 0.7576 |